Observational studyCardiovascular diabetology2023

Once-weekly glucagon-like peptide-1 receptor agonists vs dipeptidyl peptidase-4 inhibitors: cardiovascular effects in people with diabetes and cardiovascular disease.

Xi Tan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.